Medivolve Inc MEDVF

Post Covid19 Revenue Numbers

[Hiddensecrets]

The question arises as to what type of revenu numbers can we expect post covid19.    

Keep in mind that WHO has stated that the covid19 will become endemic, meaning with us forever. 

There will remain a need for testing for many reasons post covid19:
-- to test for your antibodies - which is ensuring that you are still protected 
- to test if you are positive or negative with antigen - if you no longer have the antibodies
- to test if vaccine is protecting against the various variants

The reason for continued testing is that you have to make sure that covid19 stays under control and does not resurface as it has caused monumental monetary and emotional damage. 

I will presume very conservative numbers:


We will assume that MEDV keeps 50 cubes in the future ongoing year to year.   

And we will assume that each cube does 40 tests per day, which means each cube does 1,200 tests per month or, 14,400 tests per year. 

Think of it another way, a city with 150,000 persons would mean 10% of its people get tested in one year, on and off, which is reasonable.

I assume tests will sell at an average of $ 96 USD per year.

That means recurring revenue for many years of:   $ 70,080,000 per year 

Margin rates will remain at 55% as it is high profit. 

This means earnings of:   $ 38,544,000

Earnings per share:        .23 cents per share

I have not included anything else that MEDV is doing.    

So this begs the question, how much should a company be valued at when it will earn 23 cents per share on a yearly basis for many years, without accounting for anything else?

MPO